PP2A modulation overcomes multidrug resistance in chronic lymphocytic leukemia via mPTP-dependent apoptosis is a research paper published in Journal of Clinical Investigation (2023). On theSindex it has a DataRank of 0.597. It has been cited 15 times, with 12 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.416
From this paper's citation signal
Citation Network Contribution
0.182
From 11 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 12 citers.
NCI NIH HHS
Grant: P30 CA044579
NCRR NIH HHS
Grant: S10 RR031633
NCI NIH HHS
Grant: R01 CA181654
NCI NIH HHS
Grant: R01 CA240993
National Institutes of Health
Grant: 1S10RR031633-01
ImageSteamX
National Institutes of Health
Grant: 3P30CA044579-19S1
Cancer Center Support Grant
National Institutes of Health
Grant: 5R01CA181654-06
Small Molecule Activators of PP2A (SMAPs) for Prostate Cancer Therapy
National Institutes of Health
Grant: 1R01CA240993-01
Structural and molecular determinants of protein phosphatase 2A function in lung cancer
FWCI
1.38
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals